Reports >
Life Sciences
>
Prostate Biopsy Market Report
Prostate Biopsy Market Report
First published: 14 October 2024 | Last updated: 25 May 2026 | Report Code: prostate-biopsy
Prostate Biopsy Market — USD 1.5 billion in 2023, Growing to USD 2.62B by 2033 at 5.6% CAGR
This report provides an in-depth analysis of the Prostate Biopsy market, covering key insights and data from 2023 to 2033. It includes trends, market size, segmentation, regional insights, and a forecast for future growth.
Key Takeaways
- Global market expands from $1.50 Billion in 2023 to $2.62 Billion in 2033, reflecting a 5.6% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe and Asia Pacific show notable absolute growth: Europe from $0.48 Billion to $0.83 Billion, Asia Pacific from $0.29 Billion to $0.50 Billion.
- Market adoption is supported by imaging improvements, minimally invasive techniques, and rising investment in healthcare infrastructure.
- Key participants include C. R. Bard, Inc., Merit Medical Systems, Inc., Boston Scientific Corporation, Fujifilm Holdings Corporation, and Philips Healthcare.
Prostate Biopsy Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The Prostate Biopsy market is forecast to grow from $1.50 Billion in 2023 to $2.62 Billion by 2033 at a 5.6% CAGR. Growth is propelled by technological improvements in biopsy devices and imaging, wider use of minimally invasive procedures, and increased healthcare spending. North America is the largest regional market, with other regions such as Europe and Asia Pacific contributing significant gains. Product categories include biopsy needles, biopsy devices and consumables used across hospitals, diagnostic centers and research institutes. Techniques are evolving with transrectal and transperineal approaches alongside other methods. Competitive dynamics feature established medical device companies offering integrated systems and consumables. Market momentum is reinforced by demographic trends, rising diagnostic awareness, and ongoing investment in clinical infrastructure, while stakeholders focus on safety, accuracy and workflow efficiency to optimize patient outcomes.
Key Growth Drivers
- Advances in imaging and guidance systems improving biopsy accuracy and adoption.
- Shift toward minimally invasive techniques increasing procedure volumes and patient preference.
- Rising healthcare investments and infrastructure upgrades in key regions supporting market expansion.
- Growing awareness of prostate health and increased diagnostic screening among aging populations.
- Demand for integrated solutions and consumables from hospitals, diagnostic centers and research institutes.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.50 Billion |
| CAGR (2023-2033) | 5.6% |
| 2033 Market Size | $2.62 Billion |
| Top Companies | C. R. Bard, Inc., Merit Medical Systems, Inc., Boston Scientific Corporation, Fujifilm Holdings Corporation, Philips Healthcare |
| Published Date | 14 October 2024 |
| Last Modified Date | 25 May 2026 |
Prostate Biopsy Market Overview
Customize Prostate Biopsy Market Report market research report
- ✔ Get in-depth analysis of Prostate Biopsy market size, growth, and forecasts.
- ✔ Understand Prostate Biopsy's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Prostate Biopsy
What is the Market Size & CAGR of Prostate Biopsy Market Report market in 2023?
Prostate Biopsy Industry Analysis
Prostate Biopsy Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Prostate Biopsy Market Report Market Analysis Report by Region
Europe Prostate Biopsy Market Report:
Europe grows from $0.48 Billion in 2023 to $0.83 Billion in 2033. Expansion stems from increased diagnostic screening, modernization of clinical facilities, and adoption of minimally invasive biopsy techniques across hospitals and specialist centers.Asia Pacific Prostate Biopsy Market Report:
Asia Pacific grows from $0.29 Billion in 2023 to $0.5 Billion in 2033. Growth drivers include expanding healthcare investment, growing awareness of prostate conditions, and gradual uptake of advanced biopsy devices and imaging-guided procedures.North America Prostate Biopsy Market Report:
North America is largest regional market, rising from $0.51 Billion in 2023 to $0.89 Billion in 2033. Regional strength reflects established clinical infrastructure, adoption of advanced imaging-guided biopsy systems, and high procedural volumes in hospitals and diagnostic centers.South America Prostate Biopsy Market Report:
Latin America grows from $0.02 Billion in 2023 to $0.03 Billion in 2033. Market movement is influenced by incremental healthcare infrastructure improvements, greater diagnostic access, and steady demand for basic biopsy consumables and devices.Middle East & Africa Prostate Biopsy Market Report:
Middle East and Africa grows from $0.21 Billion in 2023 to $0.37 Billion in 2033. Regional gains are linked to targeted healthcare investments, upgrading of diagnostic facilities, and increased use of minimally invasive biopsy techniques.Tell us your focus area and get a customized research report.
Research Methodology
Prostate Biopsy Market Analysis By Technique
The market for prostate biopsy techniques is segmented primarily into Transrectal Biopsy and Transperineal Biopsy. In 2023, Transrectal Biopsy accounts for the majority, valued at USD 0.99 billion, with a forecasted growth to USD 1.72 billion by 2033. Transperineal Biopsy, currently at USD 0.32 billion, is expected to rise to USD 0.55 billion. The segment showcases a growing interest due to improved safety profiles and patient acceptance.
Prostate Biopsy Market Analysis By Product
In terms of products, Biopsy Needles lead the market with a size of USD 0.99 billion in 2023, forecasted to reach USD 1.72 billion by 2033. Biopsy Devices, representing USD 0.32 billion in 2023, will grow to USD 0.55 billion, while Consumables, currently at USD 0.20 billion, will grow to USD 0.34 billion over the same period. This illustrates the critical role of innovative biopsy equipment in successful prostate cancer diagnosis.
Prostate Biopsy Market Analysis By End User
Hospitals dominate the end-user segment, holding a significant portion with USD 0.99 billion in 2023, projected to grow to USD 1.72 billion by 2033. Diagnostic Centers contribute USD 0.32 billion with a future value of USD 0.55 billion, while Research Institutes and clinics also account for meaningful shares within the diagnostic landscape. The trend indicates a shift towards outpatient procedures in various healthcare settings.
Prostate Biopsy Market Analysis By Region Type
Geographically, North America holds the largest market share, followed by Europe and Asia Pacific. Emerging economies, particularly in the Asia Pacific region, are witnessing rapid growth due to the expansion of healthcare sectors and increasing demand for diagnostic procedures. The Middle East and Africa are also slowly gaining traction as healthcare infrastructures improve.
Prostate Biopsy Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Prostate Biopsy Industry
C. R. Bard, Inc.:
A leading player in the medical device industry, known for its innovative biopsy technologies and solutions that enhance diagnostic accuracy.Merit Medical Systems, Inc.:
This company specializes in the development and manufacturing of medical devices, including a range of products for urology and biopsy procedures.Boston Scientific Corporation:
A global leader in medical solutions, Boston Scientific provides advanced technologies for diagnostic and therapeutic procedures, including prostate biopsies.Fujifilm Holdings Corporation:
Fujifilm is known for its imaging technologies used in urology, contributing significantly to advancements in prostate cancer diagnostics.Philips Healthcare:
Philips Healthcare integrates advanced imaging systems and diagnostic tools, enhancing the precision of prostate biopsy procedures.We're grateful to work with incredible clients.
FAQs
What is the market size of the Prostate Biopsy Market Report in 2023?
The market size in 2023 is $1.50 Billion as stated in the report, serving as the baseline for the 2023 to 2033 forecast period.
How big will the market be in 2033?
The market is projected to reach $2.62 Billion in 2033 according to the provided forecast figures in the report.
What is CAGR for the forecast period?
The compound annual growth rate for the 2023 to 2033 forecast period is 5.6% as specified in the report.
Is there a single fastest Growing region in the Prostate Biopsy Market Report market?
No single fastest-growing region is stated for the Prostate Biopsy Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as top participants?
Top companies cited include C. R. Bard, Inc., Merit Medical Systems, Inc., Boston Scientific Corporation, Fujifilm Holdings Corporation and Philips Healthcare.
What are the primary procedure techniques covered?
The report covers transrectal biopsy, transperineal biopsy and other techniques as the main procedural approaches referenced in the segmentation.
Who are the main end users for prostate biopsy products?
Primary end users include hospitals, diagnostic centers and research institutes that utilize biopsy devices, needles and associated consumables.
How big is the Europe market in 2023 and 2033?
Europe is reported at $0.48 Billion in 2023 and is expected to grow to $0.83 Billion by 2033 per the regional data.
What drives technology adoption in this market?
Adoption is driven by imaging enhancements, the move to minimally invasive methods, and demand for improved diagnostic accuracy and patient safety.
Why are consumables important in market structure?
Consumables, alongside devices and needles, represent recurring revenue and operational necessity for procedures performed across hospitals and diagnostic centers.